UBS Maintains Buy on AdaptHealth, Lowers Price Target to $10
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $10.
Read original at benzingaStocks · News reference
U.S. stocks gain with Nasdaq up more than 2% on Tuesday. Dow up 1.79% to 54,129.35, Nasdaq up 2.22% to 26,490.24, S&P 500 up 1.64% to 7,725.48. Tech shares jump 3.8%, utilities down 0.5%. McDonald's beats earnings estimates. Ibotta, Backblaze, Corvex up, Adapthealth, Better Home & Finance, Clearpoint Neuro down.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $10.
Read original at benzingaRBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $15 to $8.
Read original at benzingaTruist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $9.
Read original at benzingaCoinbase and Better launch a token-backed mortgage letting crypto holders buy homes without selling their assets.
Read original at benzingaThese first-of-its-kind mortgages will be originated and serviced by Better, powered by Coinbase, and designed in accordance with guidelines from Fannie Mae, making the first lien a standard, conforming mortgage.As part
Read original at benzingaVishal Garg, founder and former CEO of Better.com, filed a court opposition against the company's request for injunctive relief to halt his shareholder consent solicitation. Garg argues the Board's actions are contradictory, noting the company's own filings describe him as 'critical to operations' and shareholders re-elected him with 99.53% support in June, yet the Board terminated him in August and later offered him a $15M+ package. Better's stock fell 41.6% the day after his removal and declined nearly 60% by August 21. Garg is seeking to remove five Board members and return the company to profitability.
Read original at globenewswire-inc